Michael Pinchas Rubin
Chief Executive Officer at Northpond Ventures LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Patrick Smerkers | M | - |
Northpond Ventures LLC
 Northpond Ventures LLC Investment ManagersFinance Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland. | 6 years |
| Adam Wieschhaus | M | 41 |
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland.
SpeeDx Pty Ltd.
 SpeeDx Pty Ltd. BiotechnologyHealth Technology SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia. | 4 years |
| Andrew Leslie Denver | M | 75 |
SpeeDx Pty Ltd.
SpeeDx Pty Ltd. BiotechnologyHealth Technology SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia. | 15 years |
| Alison V. Todd | M | - |
SpeeDx Pty Ltd.
SpeeDx Pty Ltd. BiotechnologyHealth Technology SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia. | 15 years |
| Joseph Loscalzo | M | 72 |
Scipher Medicine Corp.
 Scipher Medicine Corp. Medical SpecialtiesHealth Technology Scipher Medicine Corp. operates as a biotechnology firm, which uses human data to predict drug response. It visualize overlaps between disease, drug and patient data. The company was founded in 2013 and is headquartered in Boston, MA. | 9 years |
| Albert-László Barabási | M | - |
Scipher Medicine Corp.
Scipher Medicine Corp. Medical SpecialtiesHealth Technology Scipher Medicine Corp. operates as a biotechnology firm, which uses human data to predict drug response. It visualize overlaps between disease, drug and patient data. The company was founded in 2013 and is headquartered in Boston, MA. | - |
| Elisa E. Mokany | M | - |
SpeeDx Pty Ltd.
SpeeDx Pty Ltd. BiotechnologyHealth Technology SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia. | 15 years |
| Shaan Gandhi | M | 38 |
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland. | 4 years |
| Paul Denley Hodgdon | M | - |
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland. | 4 years |
| Sharon Kedar | F | 50 |
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland. | 6 years |
| Liz Wuestling | F | - |
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland. | 4 years |
| Katie Dexter | F | - |
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland. | 3 years |
| Brandon Hoffmann | M | - |
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland. | 3 years |
| Paxton Major | M | - |
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland. | 6 years |
| Andrew Lee | M | - |
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland. | - |
| Jonathan P Goodman | M | - |
Sands Capital Ventures LLC
 Sands Capital Ventures LLC Investment ManagersFinance Sands Capital Ventures LLC (Sands Capital Ventures) is a venture capital subsidiary founded in 2010 by Frank Sands. The firm is headquartered in Arlington, Virginia. | 12 years |
| Ivan Learmont | M | - |
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland. | 3 years |
| Lynn Neff | M | - |
Scipher Medicine Corp.
Scipher Medicine Corp. Medical SpecialtiesHealth Technology Scipher Medicine Corp. operates as a biotechnology firm, which uses human data to predict drug response. It visualize overlaps between disease, drug and patient data. The company was founded in 2013 and is headquartered in Boston, MA. | - |
| Andrea Jackson | F | 45 |
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland. | 4 years |
| Camella Wilson | M | - |
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland. | 1 years |
| Lucy Coassin | F | - |
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland. | 1 years |
| Samir Kaul | M | - |
Scipher Medicine Corp.
Scipher Medicine Corp. Medical SpecialtiesHealth Technology Scipher Medicine Corp. operates as a biotechnology firm, which uses human data to predict drug response. It visualize overlaps between disease, drug and patient data. The company was founded in 2013 and is headquartered in Boston, MA. | 6 years |
| Stephen Zachary | M | 42 |
Sands Capital Ventures LLC
Sands Capital Ventures LLC Investment ManagersFinance Sands Capital Ventures LLC (Sands Capital Ventures) is a venture capital subsidiary founded in 2010 by Frank Sands. The firm is headquartered in Arlington, Virginia. | 8 years |
| Ian Ratcliffe | M | - |
Sands Capital Ventures LLC
Sands Capital Ventures LLC Investment ManagersFinance Sands Capital Ventures LLC (Sands Capital Ventures) is a venture capital subsidiary founded in 2010 by Frank Sands. The firm is headquartered in Arlington, Virginia. | 8 years |
| Michael Graninger | M | - |
Sands Capital Ventures LLC
Sands Capital Ventures LLC Investment ManagersFinance Sands Capital Ventures LLC (Sands Capital Ventures) is a venture capital subsidiary founded in 2010 by Frank Sands. The firm is headquartered in Arlington, Virginia. | 6 years |
| Miklos Kobor | M | - |
Scipher Medicine Corp.
Scipher Medicine Corp. Medical SpecialtiesHealth Technology Scipher Medicine Corp. operates as a biotechnology firm, which uses human data to predict drug response. It visualize overlaps between disease, drug and patient data. The company was founded in 2013 and is headquartered in Boston, MA. | - |
| Diana Bernstein | M | - |
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland. | - |
| Colin Denver | M | - |
SpeeDx Pty Ltd.
SpeeDx Pty Ltd. BiotechnologyHealth Technology SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia. | - |
| Ingo Chakravarty | M | - |
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland. | 1 years |
| Michael Ginder | M | - |
Sands Capital Ventures LLC
Sands Capital Ventures LLC Investment ManagersFinance Sands Capital Ventures LLC (Sands Capital Ventures) is a venture capital subsidiary founded in 2010 by Frank Sands. The firm is headquartered in Arlington, Virginia. | 13 years |
| Jennifer Maher | F | - |
SpeeDx Pty Ltd.
SpeeDx Pty Ltd. BiotechnologyHealth Technology SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia. | - |
| John E. Klopp | M | - |
SpeeDx Pty Ltd.
SpeeDx Pty Ltd. BiotechnologyHealth Technology SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia. | 14 years |
| Todd Sone | M | 53 |
Scipher Medicine Corp.
Scipher Medicine Corp. Medical SpecialtiesHealth Technology Scipher Medicine Corp. operates as a biotechnology firm, which uses human data to predict drug response. It visualize overlaps between disease, drug and patient data. The company was founded in 2013 and is headquartered in Boston, MA. | 3 years |
| Chandrashekhar J. Joshi | M | - |
University of California, Los Angeles
| 26 years |
| Erin Soule | F | - |
Sands Capital Ventures LLC
Sands Capital Ventures LLC Investment ManagersFinance Sands Capital Ventures LLC (Sands Capital Ventures) is a venture capital subsidiary founded in 2010 by Frank Sands. The firm is headquartered in Arlington, Virginia. | 10 years |
| Albert Carnesale | M | 87 |
University of California, Los Angeles
| 27 years |
| Monet Uva | F | - |
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland. | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Furmanski Chris | M | - |
University of California, Los Angeles
| 6 years |
| Dan Beaney | M | - |
University of California, Los Angeles
| 5 years |
| Daniel Janse | M | - |
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland. | 2 years |
| Elemer Piros | M | - |
University of California, Los Angeles
| 8 years |
| Justin M. Sobaje | M | - |
University of California, Los Angeles
| 5 years |
| Edward Fan | M | - |
University of California, Los Angeles
| 5 years |
| Paul B. Thomas | M | - |
University of California, Los Angeles
| 11 years |
| Wing Cheung Hwang | M | 48 |
University of California, Los Angeles
| 6 years |
| Brian Lowery | M | - |
University of California, Los Angeles
| 5 years |
| Matt MacKenzie | M | - |
University of California, Los Angeles
| 7 years |
| Alya H. Hidayatallah | F | 48 |
University of California, Los Angeles
| 4 years |
| Steven M. Buxbaum | M | 56 |
University of California, Los Angeles
| 2 years |
| Mary Karol Cline | M | - |
University of California, Los Angeles
| 3 years |
| Morris Rafi | M | - |
University of California, Los Angeles
| 4 years |
| Min-Soo Kim | M | - |
University of California, Los Angeles
| 4 years |
| Kern Schireson | M | - |
University of California, Los Angeles
| 4 years |
| Shirley Lee | F | - |
University of California, Los Angeles
| 4 years |
| Randy O'Toole | M | - |
University of California, Los Angeles
| 2 years |
| Anil Shankar | M | - |
University of California, Los Angeles
| 4 years |
| Steven Chao | M | - |
University of California, Los Angeles
| 4 years |
| Avi Padhye | M | - |
University of California, Los Angeles
| 3 years |
| Sunitha Ramaswamy | F | - |
The Isenberg School of Management
| 2 years |
| Pik Wah Yeung | M | 55 |
University of California, Los Angeles
| 4 years |
| Marc Yassinger | M | - |
University of California, Los Angeles
| 4 years |
| Tyler Mingst | M | - |
University of California, Los Angeles
| - |
| JACQUIE KUSH | F | - |
University of California, Los Angeles
| 4 years |
| Abigail L. Ocampo | F | - |
University of California, Los Angeles
| 4 years |
| Neel Bhatia | M | - |
University of California, Los Angeles
| 5 years |
| Bjorn Sperber | M | - |
University of California, Los Angeles
| 4 years |
| Robert Stevenson | M | - |
University of California, Los Angeles
| 5 years |
| Jason Young | M | - |
University of California, Los Angeles
| 4 years |
| Paul Martini | M | - |
University of California, Los Angeles
| 4 years |
| Amir Chaudhri | M | - |
University of California, Los Angeles
| 4 years |
| Bob Grundstrom | M | - |
University of California, Los Angeles
| 4 years |
| Tenny Febyana Halim | F | 50 |
University of California, Los Angeles
| 4 years |
| Marcelo Choi | M | - |
University of California, Los Angeles
| 5 years |
| Ashok S. Ramji | M | - |
University of California, Los Angeles
| 5 years |
| Steven Charles DeLuca | M | 60 |
University of California, Los Angeles
| 2 years |
| Aaron Kessler | M | - |
University of California, Los Angeles
| 4 years |
| Ben Bisconti | M | - |
University of California, Los Angeles
| - |
| Robert P. Bennett | M | - |
University of California, Los Angeles
| 2 years |
| John A. Solarczyk | M | - |
University of California, Los Angeles
| 4 years |
| Alex Manzo | M | - |
University of California, Los Angeles
| 4 years |
| Christian Chan | M | - |
University of California, Los Angeles
| 4 years |
| Jim Schnieders | M | - |
University of California, Los Angeles
| 4 years |
| Michael A. Hedge | M | - |
University of California, Los Angeles
| 3 years |
| Wandy Yeap Hoh | F | - |
University of California, Los Angeles
| 4 years |
| George Kase | M | - |
University of California, Los Angeles
| 5 years |
| Jose Luis Wynne | M | - |
University of California, Los Angeles
| 5 years |
| Melanie Jocson | F | - |
University of California, Los Angeles
| 4 years |
| Jed W. Lassere | M | - |
University of California, Los Angeles
| 4 years |
| Jackie Liu | F | - |
University of California, Los Angeles
| 4 years |
| Stephen Burns | M | - |
University of California, Los Angeles
| 7 years |
| Jason Doren | M | 54 |
University of California, Los Angeles
| 3 years |
| Kamran Moghtaderi | M | - |
University of California, Los Angeles
| 4 years |
| Robert M. Kashian | M | - |
University of California, Los Angeles
| 4 years |
| Joseph Sooren Simonian | M | - |
University of California, Los Angeles
| 5 years |
| Jason Medbury | M | - |
University of California, Los Angeles
| 4 years |
| Luke Johnson | M | - |
University of California, Los Angeles
| 4 years |
| Anicia Mendez | F | - |
University of California, Los Angeles
| 5 years |
| Erik Paul Gulsrud | M | - |
University of California, Los Angeles
| 4 years |
| Michael L. Weiner | M | 75 |
University of California, Los Angeles
| 3 years |
| Tim Riley | M | - |
University of California, Los Angeles
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 94 | 94.00% |
| Australia | 7 | 7.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael Pinchas Rubin
- Personal Network
